Latest News in the pharma Industry

Policy & Regulation

Lilly's Cyramza (ramucirumab) Receives Third FDA Approval

Lilly's Cyramza (ramucirumab) Receives Third FDA Approval

17 Dec 2014

Read more 
Novartis Gains FDA Approval for Signifor LAR to Treat Patients with Acromegaly

Novartis Gains FDA Approval for Signifor LAR to Treat Patients with Acromegaly

16 Dec 2014

Read more 
Adults Living with Ulcerated Colitis Will Have Treatment Option of AbbVie’s Anti-TNF Humira

Adults Living with Ulcerated Colitis Will Have Treatment Option of AbbVie’s Anti-TNF Humira

15 Dec 2014

Read more 
FDA Approves Merck's HPV Vaccine, Gardasil 9

FDA Approves Merck's HPV Vaccine, Gardasil 9

12 Dec 2014

Read more 
GVK Biosciences Review: Some Member States Suspend Marketing Authorisations for Concerned Medicines

GVK Biosciences Review: Some Member States Suspend Marketing Authorisations for Concerned Medicines

8 Dec 2014

Read more 
FDA Issues Guidance Helping Manufacturers Gain Access to REMS Drugs for Generic Development?

FDA Issues Guidance Helping Manufacturers Gain Access to REMS Drugs for Generic Development?

5 Dec 2014

Read more 
Mylan Receives Tentative FDA approval for Paediatric Formulations of Abacavir/Lamivudine Through Innovative Collaboration

Mylan Receives Tentative FDA approval for Paediatric Formulations of Abacavir/Lamivudine Through Innovative Collaboration

5 Dec 2014

Read more 
FDA Approves Amgen's Blincyto (Blinatumomab) Immunotherapy

FDA Approves Amgen's Blincyto (Blinatumomab) Immunotherapy

4 Dec 2014

Read more 
Novartis Drug Signifor Approved in EU, Marking an Advance for Patients with Inadequately Controlled Acromegaly

Novartis Drug Signifor Approved in EU, Marking an Advance for Patients with Inadequately Controlled Acromegaly

27 Nov 2014

Read more 
Merck Submits NDA to the Japanese Pharmaceuticals and Medical Devices Agency for Omarigliptin for Type 2 Diabetes

Merck Submits NDA to the Japanese Pharmaceuticals and Medical Devices Agency for Omarigliptin for Type 2 Diabetes

25 Nov 2014

Read more 
HHS and NIH Take Steps to Enhance Transparency of Clinical Trial Results

HHS and NIH Take Steps to Enhance Transparency of Clinical Trial Results

20 Nov 2014

Read more 
FDA Approves Genentech’s Avastin (Bevacizumab) Plus Chemotherapy to Treat Women with Platinum-Resistant Recurrent Ovarian Cancer

FDA Approves Genentech’s Avastin (Bevacizumab) Plus Chemotherapy to Treat Women with Platinum-Resistant Recurrent Ovarian Cancer

17 Nov 2014

Read more